Lung Cancer
News
ELCC: Survey reveals worldwide underuse of EGFR-mutation testing
Key clinical point: A significant minority of advanced lung cancer patients worldwide fail to receive initial treatment guided by EGFR-mutation...
Conference Coverage
VIDEO: Level of e-cigarette power contributes to potentially hazardous effects
News
Statin use associated with reduced lung cancer mortality
Conference Coverage
ELCC: Urine tumor DNA shows high testing promise
Key clinical point: Urine showed potential as a fully noninvasive source for circulating tumor DNA with high testing concordance compared with...
News
New agent targets EGFR resistance in NSCLC
Key clinical point: AZD9291 was highly active against advanced NSCLC that had mutated to become resistant to treatment with EGFR tyrosine kinase...
News
Rociletinib active against resistant NSCLC
Key clinical point: Rociletinib exerted prolonged disease control in a phase I study of resistant non–small cell lung cancer. Major finding: After...
News
Lung adenocarcinoma subtype predicts benefit from adjuvant chemotherapy
Key clinical point: Invasive adenocarcinomas with micropapillary (MIP) and predominantly solid (SOL) patterns had greater benefit from adjuvant...
Conference Coverage
ASA: Tumors glow green in new ‘optical biopsy’ technique
Key clinical point: Fluorescein-tagged tumors glowed visibly and allowed accurate detection of pulmonary adenocarcinomas. Major finding: A novel...
News
ELCC: NSCLC mutation testing highlights ctDNA’s limitations
Key clinical point: In a real-world setting genetic tests that used ctDNA to find treatment-determining mutations in patients with advanced lung...
News
AACR: KEYNOTE-001 takes step toward PD-L1 blocker biomarker
Key clinical point: Pembrolizumab provided durable responses in NSCLC, with clinical outcomes correlating with a proposed biomarker. Major finding...